Walmart asks Chinese suppliers for major price cuts on Trump tariffs, Bloomberg News reports-February 2024-www.financetom.com

Walmart asks Chinese suppliers for major price cuts on Trump tariffs, Bloomberg News reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Walmart asks Chinese suppliers for major price cuts on Trump tariffs, Bloomberg News reports

Mar 6, 2025 2:07 AM

March 6 (Reuters) - Walmart ( WMT ) has asked some

Chinese suppliers for major price cuts, with the U.S. retail

giant's efforts to shift the burden of President Donald Trump's

tariffs facing strong push back from firms in the Asian nation,

Bloomberg News reported on Thursday.

Previous page： Pop-Tarts maker Kellanova beats quarterly sales, profit estimates on steady demand Next page： Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pop-Tarts maker Kellanova beats quarterly sales, profit estimates on steady demand

Feb 6, 2025

Feb 6 (Reuters) - Packaged food company Kellanova ( K ) beat Wall Street expectations for fourth-quarter earnings on Thursday, on the back of steady demand for its snacks and breakfast cereals such as Pringles and Cheez-It. While other packaged food companies such as Conagra and McCormick ( MKC ) are facing a demand slowdown as customers cut back on...

Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma

Feb 6, 2025

09:04 AM EST, 02/06/2025 (MT Newswires) -- Merck ( MRK ) said Thursday that it has initiated a pivotal phase 3 clinical trial evaluating zilovertamab vedotin, an investigational antibody-drug conjugate to treat patients with previously untreated diffuse large B-cell lymphoma. The company said the trial will combine zilovertamab vedotin with rituximab plus cyclophosphamide, doxorubicin and prednisone, compared with rituximab plus...

Sonos Fiscal Q1 Non-GAAP Net Income, Revenue Decrease

Feb 6, 2025

09:04 AM EST, 02/06/2025 (MT Newswires) -- Sonos ( SONO ) reported fiscal Q1 non-GAAP net income Thursday of $0.64 per diluted share, down from $0.84 a year earlier. Three analysts polled by FactSet expected $0.30. Revenue for the fiscal quarter ended Dec. 28 was $550.9 million, down from $612.9 million a year earlier. Analysts surveyed by FactSet expected $519.8...

Ride-hailing platform Lyft ties up with Anthropic for AI-powered customer care

Feb 6, 2025

Feb 6 (Reuters) - Lyft ( LYFT ) said on Thursday it has tied up with Amazon ( AMZN ) and Alphabet-backed startup Anthropic to roll out artificial intelligence tools for the ride-hailing platform's customer care operations. The company said it has been using Anthropic's Claude AI model, through Amazon's ( AMZN ) Bedrock generative AI platform, which has helped...